Ionis Pharmaceuticals (IONS) Other Gross PP&E Adjustments: 2010-2025
Historic Other Gross PP&E Adjustments for Ionis Pharmaceuticals (IONS) over the last 3 years, with Sep 2025 value amounting to -$242.0 million.
- Ionis Pharmaceuticals' Other Gross PP&E Adjustments fell 47.18% to -$242.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$617.7 million, marking a year-over-year decrease of 4.53%. This contributed to the annual value of -$52.5 million for FY2024, which is 41.73% up from last year.
- Ionis Pharmaceuticals' Other Gross PP&E Adjustments amounted to -$242.0 million in Q3 2025, which was down 47.62% from -$163.9 million recorded in Q2 2025.
- In the past 5 years, Ionis Pharmaceuticals' Other Gross PP&E Adjustments ranged from a high of $153.1 million in Q4 2021 and a low of -$242.0 million during Q3 2025.
- Moreover, its 3-year median value for Other Gross PP&E Adjustments was -$166.9 million (2024), whereas its average is -$158.1 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first tumbled by 175.18% in 2022, then skyrocketed by 41.73% in 2024.
- Quarterly analysis of 5 years shows Ionis Pharmaceuticals' Other Gross PP&E Adjustments stood at $153.1 million in 2021, then plummeted by 175.18% to -$115.1 million in 2022, then grew by 21.68% to -$90.1 million in 2023, then soared by 41.73% to -$52.5 million in 2024, then plummeted by 47.18% to -$242.0 million in 2025.
- Its Other Gross PP&E Adjustments was -$242.0 million in Q3 2025, compared to -$163.9 million in Q2 2025 and -$159.3 million in Q1 2025.